 Katerina Kechris
Concepts (492)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 15 | 2022 | 508 | 3.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 19 | 2023 | 902 | 2.640 |
Why?
| | Algorithms | 12 | 2023 | 1462 | 2.120 |
Why?
| | Gene Expression Profiling | 19 | 2021 | 1510 | 1.990 |
Why?
| | DNA Methylation | 15 | 2023 | 493 | 1.980 |
Why?
| | Sequence Analysis, RNA | 9 | 2021 | 387 | 1.890 |
Why?
| | Bayes Theorem | 10 | 2023 | 325 | 1.860 |
Why?
| | MicroRNAs | 10 | 2023 | 600 | 1.800 |
Why?
| | Genome-Wide Association Study | 9 | 2023 | 1157 | 1.680 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2021 | 435 | 1.610 |
Why?
| | Software | 12 | 2021 | 525 | 1.600 |
Why?
| | Mass Spectrometry | 6 | 2022 | 616 | 1.560 |
Why?
| | Data Interpretation, Statistical | 5 | 2020 | 315 | 1.290 |
Why?
| | Computational Biology | 6 | 2017 | 527 | 1.270 |
Why?
| | Quantitative Trait Loci | 14 | 2020 | 300 | 1.250 |
Why?
| | Gene Expression Regulation | 12 | 2022 | 2293 | 1.230 |
Why?
| | Models, Genetic | 7 | 2019 | 542 | 1.150 |
Why?
| | Polymorphism, Single Nucleotide | 10 | 2023 | 1856 | 1.100 |
Why?
| | Gene Regulatory Networks | 4 | 2023 | 229 | 1.030 |
Why?
| | Phenotype | 20 | 2023 | 2754 | 0.970 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2021 | 739 | 0.960 |
Why?
| | Prenatal Exposure Delayed Effects | 9 | 2023 | 453 | 0.950 |
Why?
| | Gene Expression | 10 | 2021 | 1397 | 0.900 |
Why?
| | Transcriptome | 9 | 2021 | 719 | 0.890 |
Why?
| | Brain | 8 | 2023 | 2309 | 0.840 |
Why?
| | Databases, Factual | 6 | 2021 | 1127 | 0.840 |
Why?
| | Metabolome | 4 | 2021 | 275 | 0.790 |
Why?
| | Models, Statistical | 5 | 2020 | 593 | 0.770 |
Why?
| | Propensity Score | 1 | 2023 | 225 | 0.770 |
Why?
| | Emphysema | 4 | 2023 | 105 | 0.760 |
Why?
| | Ethanol | 5 | 2020 | 532 | 0.730 |
Why?
| | Conserved Sequence | 3 | 2009 | 215 | 0.680 |
Why?
| | Pulmonary Emphysema | 6 | 2023 | 265 | 0.660 |
Why?
| | User-Computer Interface | 1 | 2020 | 139 | 0.660 |
Why?
| | RNA | 4 | 2021 | 801 | 0.650 |
Why?
| | Biomarkers | 18 | 2022 | 3390 | 0.640 |
Why?
| | Adiposity | 8 | 2023 | 458 | 0.630 |
Why?
| | Fluorocarbons | 4 | 2023 | 94 | 0.620 |
Why?
| | Computer Simulation | 7 | 2023 | 858 | 0.590 |
Why?
| | Health Status | 1 | 2023 | 716 | 0.590 |
Why?
| | Epigenesis, Genetic | 10 | 2023 | 515 | 0.590 |
Why?
| | Humans | 85 | 2023 | 113546 | 0.590 |
Why?
| | Proteomics | 2 | 2021 | 809 | 0.580 |
Why?
| | Smoking | 7 | 2019 | 1380 | 0.570 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 133 | 0.550 |
Why?
| | Animals | 34 | 2023 | 31165 | 0.550 |
Why?
| | ROC Curve | 5 | 2020 | 442 | 0.550 |
Why?
| | Linear Models | 4 | 2019 | 767 | 0.540 |
Why?
| | Genomics | 4 | 2017 | 625 | 0.540 |
Why?
| | Pediatric Obesity | 5 | 2023 | 490 | 0.540 |
Why?
| | Islets of Langerhans | 5 | 2023 | 728 | 0.530 |
Why?
| | Alcoholism | 3 | 2020 | 704 | 0.520 |
Why?
| | Models, Theoretical | 1 | 2020 | 505 | 0.520 |
Why?
| | Diabetes Mellitus, Type 1 | 9 | 2023 | 3252 | 0.500 |
Why?
| | Glycosphingolipids | 1 | 2015 | 8 | 0.480 |
Why?
| | Placenta | 5 | 2023 | 627 | 0.480 |
Why?
| | Drosophila | 3 | 2010 | 130 | 0.470 |
Why?
| | Environmental Pollutants | 3 | 2023 | 110 | 0.470 |
Why?
| | Female | 55 | 2023 | 59125 | 0.460 |
Why?
| | Mice | 19 | 2022 | 14682 | 0.460 |
Why?
| | Maternal Exposure | 4 | 2022 | 138 | 0.450 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.440 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1282 | 0.440 |
Why?
| | Nitrogenase | 2 | 2013 | 8 | 0.440 |
Why?
| | Case-Control Studies | 13 | 2023 | 2993 | 0.430 |
Why?
| | Smoking Cessation | 1 | 2017 | 373 | 0.430 |
Why?
| | Schistosomiasis japonica | 3 | 2022 | 32 | 0.420 |
Why?
| | RNA, Messenger | 7 | 2023 | 2507 | 0.420 |
Why?
| | Markov Chains | 2 | 2020 | 114 | 0.410 |
Why?
| | Genetic Predisposition to Disease | 10 | 2021 | 2077 | 0.410 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1421 | 0.410 |
Why?
| | DNA | 3 | 2019 | 1331 | 0.410 |
Why?
| | Genotype | 6 | 2020 | 1733 | 0.400 |
Why?
| | Autoimmunity | 7 | 2023 | 813 | 0.400 |
Why?
| | Sample Size | 3 | 2023 | 107 | 0.400 |
Why?
| | Diabetes, Gestational | 3 | 2023 | 281 | 0.390 |
Why?
| | Phylogeny | 2 | 2013 | 783 | 0.390 |
Why?
| | Lung | 5 | 2023 | 3497 | 0.370 |
Why?
| | Schistosoma japonicum | 2 | 2022 | 31 | 0.370 |
Why?
| | Transcription Factors | 5 | 2023 | 1497 | 0.360 |
Why?
| | Pregnancy | 17 | 2023 | 5490 | 0.360 |
Why?
| | Support Vector Machine | 2 | 2021 | 34 | 0.360 |
Why?
| | Bias | 2 | 2022 | 178 | 0.360 |
Why?
| | Area Under Curve | 3 | 2020 | 271 | 0.350 |
Why?
| | Genome, Human | 3 | 2019 | 342 | 0.350 |
Why?
| | Male | 42 | 2023 | 55122 | 0.340 |
Why?
| | Binding Sites | 5 | 2021 | 1153 | 0.330 |
Why?
| | Molybdoferredoxin | 1 | 2009 | 12 | 0.330 |
Why?
| | Gastrointestinal Tract | 2 | 2022 | 168 | 0.330 |
Why?
| | Insulin | 6 | 2023 | 2076 | 0.330 |
Why?
| | Oxidoreductases | 1 | 2009 | 89 | 0.310 |
Why?
| | Signal Transduction | 7 | 2020 | 4439 | 0.310 |
Why?
| | Mycobacterium tuberculosis | 3 | 2016 | 268 | 0.310 |
Why?
| | CpG Islands | 4 | 2021 | 118 | 0.300 |
Why?
| | Infant, Newborn | 14 | 2023 | 5032 | 0.300 |
Why?
| | Exons | 1 | 2008 | 300 | 0.290 |
Why?
| | Fetal Blood | 7 | 2023 | 266 | 0.290 |
Why?
| | HIV-1 | 3 | 2022 | 764 | 0.280 |
Why?
| | Alcohol Drinking | 5 | 2014 | 651 | 0.280 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2022 | 578 | 0.280 |
Why?
| | Cohort Studies | 10 | 2023 | 4880 | 0.280 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2021 | 280 | 0.280 |
Why?
| | Leukocytes, Mononuclear | 3 | 2015 | 487 | 0.280 |
Why?
| | Alternative Splicing | 1 | 2008 | 184 | 0.280 |
Why?
| | Child | 22 | 2023 | 18347 | 0.280 |
Why?
| | Environmental Exposure | 2 | 2020 | 370 | 0.270 |
Why?
| | HIV Infections | 4 | 2022 | 2440 | 0.270 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 172 | 0.260 |
Why?
| | Tuberculosis | 2 | 2020 | 239 | 0.250 |
Why?
| | Genome | 3 | 2013 | 260 | 0.250 |
Why?
| | Prospective Studies | 9 | 2023 | 6191 | 0.240 |
Why?
| | Alkanesulfonic Acids | 2 | 2023 | 28 | 0.240 |
Why?
| | Mice, Inbred C57BL | 5 | 2019 | 4619 | 0.240 |
Why?
| | Principal Component Analysis | 2 | 2023 | 174 | 0.240 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 113 | 0.230 |
Why?
| | Oxylipins | 2 | 2023 | 27 | 0.230 |
Why?
| | Mice, Inbred Strains | 4 | 2020 | 394 | 0.230 |
Why?
| | Reproducibility of Results | 3 | 2021 | 2752 | 0.230 |
Why?
| | Quantitative Trait, Heritable | 3 | 2017 | 115 | 0.230 |
Why?
| | Severity of Illness Index | 5 | 2021 | 2532 | 0.230 |
Why?
| | Seroconversion | 2 | 2021 | 45 | 0.220 |
Why?
| | Melanocytes | 2 | 2015 | 54 | 0.220 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 43 | 0.220 |
Why?
| | Diet | 2 | 2021 | 1076 | 0.220 |
Why?
| | Cluster Analysis | 2 | 2023 | 448 | 0.220 |
Why?
| | Child, Preschool | 12 | 2023 | 9097 | 0.220 |
Why?
| | Middle Aged | 17 | 2021 | 26558 | 0.220 |
Why?
| | Sequence Analysis, DNA | 2 | 2019 | 716 | 0.210 |
Why?
| | Genetic Association Studies | 3 | 2020 | 333 | 0.210 |
Why?
| | Breast Neoplasms | 3 | 2019 | 1842 | 0.210 |
Why?
| | Lipid Metabolism | 3 | 2023 | 438 | 0.210 |
Why?
| | Birth Weight | 3 | 2023 | 440 | 0.210 |
Why?
| | Infant | 11 | 2023 | 7923 | 0.210 |
Why?
| | Mothers | 3 | 2023 | 651 | 0.200 |
Why?
| | Phospholipids | 2 | 2021 | 192 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 17 | 0.200 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 128 | 0.200 |
Why?
| | Schistosomiasis | 1 | 2022 | 37 | 0.190 |
Why?
| | Mutation | 3 | 2021 | 3313 | 0.190 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1682 | 0.190 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 57 | 0.190 |
Why?
| | Endemic Diseases | 1 | 2021 | 23 | 0.190 |
Why?
| | Aged | 12 | 2021 | 18945 | 0.190 |
Why?
| | Selection Bias | 1 | 2021 | 33 | 0.190 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 54 | 0.190 |
Why?
| | Immunoglobulin A | 1 | 2022 | 166 | 0.180 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2021 | 29 | 0.180 |
Why?
| | Cloud Computing | 1 | 2021 | 6 | 0.180 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.180 |
Why?
| | Central Nervous System Depressants | 2 | 2012 | 80 | 0.180 |
Why?
| | Genome, Viral | 1 | 2021 | 118 | 0.180 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 40 | 0.180 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 92 | 0.180 |
Why?
| | Normal Distribution | 2 | 2018 | 19 | 0.180 |
Why?
| | Population Dynamics | 1 | 2021 | 122 | 0.180 |
Why?
| | Polyadenylation | 1 | 2021 | 37 | 0.180 |
Why?
| | Biostatistics | 1 | 2020 | 15 | 0.170 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 93 | 0.170 |
Why?
| | Drug Tolerance | 1 | 2020 | 77 | 0.170 |
Why?
| | Probability | 1 | 2021 | 285 | 0.170 |
Why?
| | Premature Birth | 1 | 2023 | 274 | 0.170 |
Why?
| | Travel | 1 | 2021 | 117 | 0.170 |
Why?
| | Liver | 2 | 2019 | 1630 | 0.170 |
Why?
| | Interferon-beta | 1 | 2020 | 78 | 0.170 |
Why?
| | Monte Carlo Method | 1 | 2020 | 136 | 0.170 |
Why?
| | Air Pollution | 1 | 2022 | 166 | 0.170 |
Why?
| | Smoke | 2 | 2023 | 122 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 133 | 0.170 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2020 | 170 | 0.170 |
Why?
| | Discriminant Analysis | 1 | 2020 | 36 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 244 | 0.170 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 69 | 0.170 |
Why?
| | Sex Characteristics | 2 | 2023 | 633 | 0.170 |
Why?
| | Disease Progression | 4 | 2022 | 2364 | 0.170 |
Why?
| | Decision Trees | 1 | 2020 | 81 | 0.170 |
Why?
| | Proteome | 1 | 2023 | 335 | 0.170 |
Why?
| | Rats | 4 | 2023 | 4829 | 0.170 |
Why?
| | Atherosclerosis | 1 | 2023 | 342 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2020 | 184 | 0.160 |
Why?
| | Air Pollutants | 1 | 2022 | 239 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.160 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 322 | 0.160 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 97 | 0.160 |
Why?
| | Marijuana Use | 1 | 2022 | 166 | 0.160 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 44 | 0.160 |
Why?
| | Autoantibodies | 3 | 2022 | 1349 | 0.150 |
Why?
| | Base Sequence | 3 | 2021 | 2080 | 0.150 |
Why?
| | Antiviral Agents | 2 | 2021 | 635 | 0.150 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 14 | 0.150 |
Why?
| | Reflex, Righting | 1 | 2018 | 10 | 0.150 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 251 | 0.150 |
Why?
| | Adult | 16 | 2023 | 30251 | 0.150 |
Why?
| | Rural Population | 1 | 2021 | 441 | 0.150 |
Why?
| | Receptor, Insulin | 1 | 2017 | 93 | 0.140 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2017 | 9 | 0.140 |
Why?
| | Receptors, GABA-A | 1 | 2018 | 81 | 0.140 |
Why?
| | Dendritic Cells | 1 | 2020 | 432 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 244 | 0.140 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 112 | 0.140 |
Why?
| | Epigenomics | 2 | 2018 | 98 | 0.140 |
Why?
| | Adolescent | 8 | 2023 | 17731 | 0.140 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 336 | 0.140 |
Why?
| | Otitis Media | 1 | 2019 | 142 | 0.140 |
Why?
| | Alleles | 1 | 2019 | 781 | 0.140 |
Why?
| | DNA-Binding Proteins | 3 | 2019 | 1286 | 0.140 |
Why?
| | Down-Regulation | 1 | 2019 | 593 | 0.140 |
Why?
| | Risk Factors | 6 | 2023 | 8607 | 0.130 |
Why?
| | Longevity | 1 | 2017 | 135 | 0.130 |
Why?
| | Predictive Value of Tests | 3 | 2017 | 1784 | 0.130 |
Why?
| | Biomedical Research | 2 | 2020 | 582 | 0.130 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 177 | 0.130 |
Why?
| | Chemokines | 1 | 2017 | 215 | 0.130 |
Why?
| | Age Factors | 2 | 2021 | 2875 | 0.130 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 156 | 0.130 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 177 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 170 | 0.130 |
Why?
| | Obesity | 4 | 2023 | 2502 | 0.130 |
Why?
| | Keratinocytes | 1 | 2017 | 215 | 0.130 |
Why?
| | Plasma | 1 | 2017 | 180 | 0.130 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 465 | 0.130 |
Why?
| | Aged, 80 and over | 8 | 2021 | 6296 | 0.130 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 7 | 0.130 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 54 | 0.130 |
Why?
| | Databases, Genetic | 2 | 2021 | 205 | 0.130 |
Why?
| | Corpus Luteum | 1 | 2015 | 19 | 0.130 |
Why?
| | Infant, Premature | 1 | 2019 | 479 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 498 | 0.120 |
Why?
| | Cannabis | 1 | 2022 | 382 | 0.120 |
Why?
| | Granulosa Cells | 1 | 2015 | 29 | 0.120 |
Why?
| | Tobacco Products | 1 | 2016 | 96 | 0.120 |
Why?
| | Ultraviolet Therapy | 1 | 2015 | 16 | 0.120 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.120 |
Why?
| | Child Development | 1 | 2019 | 381 | 0.120 |
Why?
| | Sphingomyelins | 1 | 2015 | 26 | 0.120 |
Why?
| | Vitiligo | 1 | 2015 | 41 | 0.120 |
Why?
| | Microarray Analysis | 2 | 2012 | 118 | 0.120 |
Why?
| | Epithelial Cells | 1 | 2020 | 940 | 0.120 |
Why?
| | Fatty Acids | 1 | 2017 | 380 | 0.120 |
Why?
| | Hair | 1 | 2015 | 65 | 0.120 |
Why?
| | Blood Proteins | 1 | 2016 | 217 | 0.120 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 31 | 0.120 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 218 | 0.120 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2741 | 0.110 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 155 | 0.110 |
Why?
| | Caloric Restriction | 1 | 2015 | 88 | 0.110 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 129 | 0.110 |
Why?
| | STAT2 Transcription Factor | 1 | 2013 | 3 | 0.110 |
Why?
| | CCCTC-Binding Factor | 1 | 2013 | 12 | 0.110 |
Why?
| | Microbiota | 1 | 2021 | 646 | 0.110 |
Why?
| | Species Specificity | 2 | 2012 | 531 | 0.110 |
Why?
| | Gangliosides | 1 | 2013 | 18 | 0.110 |
Why?
| | G-Quadruplexes | 1 | 2013 | 15 | 0.110 |
Why?
| | Antitubercular Agents | 1 | 2015 | 169 | 0.110 |
Why?
| | Myocardium | 1 | 2018 | 906 | 0.110 |
Why?
| | Saccharomyces | 1 | 2013 | 6 | 0.110 |
Why?
| | Dietary Fats | 1 | 2015 | 286 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1140 | 0.110 |
Why?
| | Choice Behavior | 1 | 2014 | 148 | 0.110 |
Why?
| | Longitudinal Studies | 4 | 2021 | 2363 | 0.100 |
Why?
| | Sequence Alignment | 1 | 2013 | 321 | 0.100 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2015 | 283 | 0.100 |
Why?
| | DNA Probes | 1 | 2012 | 59 | 0.100 |
Why?
| | Programming Languages | 1 | 2012 | 22 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 112 | 0.100 |
Why?
| | Tretinoin | 1 | 2013 | 122 | 0.100 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1076 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 3 | 2021 | 2269 | 0.100 |
Why?
| | Teratogens | 1 | 2012 | 8 | 0.100 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 357 | 0.100 |
Why?
| | Weight Gain | 1 | 2015 | 454 | 0.100 |
Why?
| | Protein Binding | 2 | 2021 | 1867 | 0.100 |
Why?
| | Body Mass Index | 4 | 2023 | 1952 | 0.100 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 25 | 0.100 |
Why?
| | Adiponectin | 1 | 2013 | 209 | 0.100 |
Why?
| | China | 2 | 2022 | 161 | 0.090 |
Why?
| | Young Adult | 7 | 2020 | 10405 | 0.090 |
Why?
| | Triglycerides | 2 | 2023 | 464 | 0.090 |
Why?
| | Regression Analysis | 3 | 2021 | 932 | 0.090 |
Why?
| | Stem Cells | 1 | 2015 | 538 | 0.090 |
Why?
| | Chromosome Mapping | 3 | 2020 | 476 | 0.090 |
Why?
| | Body Weight | 1 | 2015 | 853 | 0.090 |
Why?
| | Dysbiosis | 2 | 2022 | 144 | 0.090 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 76 | 0.090 |
Why?
| | Pain Threshold | 1 | 2010 | 66 | 0.090 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 79 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2013 | 358 | 0.090 |
Why?
| | Asthma | 1 | 2023 | 2017 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2012 | 777 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 488 | 0.090 |
Why?
| | Cytokines | 1 | 2017 | 1795 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2015 | 717 | 0.080 |
Why?
| | Morphine | 1 | 2010 | 121 | 0.080 |
Why?
| | Internet | 2 | 2010 | 590 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 1956 | 0.080 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 171 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 984 | 0.080 |
Why?
| | Vital Capacity | 2 | 2021 | 249 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2012 | 1208 | 0.080 |
Why?
| | Drosophila Proteins | 1 | 2010 | 159 | 0.080 |
Why?
| | Spirometry | 2 | 2021 | 220 | 0.080 |
Why?
| | Synaptic Transmission | 1 | 2010 | 227 | 0.080 |
Why?
| | Gestational Age | 2 | 2023 | 762 | 0.080 |
Why?
| | Fasting | 2 | 2023 | 242 | 0.080 |
Why?
| | Yeasts | 1 | 2008 | 49 | 0.080 |
Why?
| | Food Preferences | 1 | 2009 | 108 | 0.080 |
Why?
| | Glycerophospholipids | 2 | 2018 | 26 | 0.070 |
Why?
| | Forced Expiratory Volume | 2 | 2021 | 468 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 148 | 0.070 |
Why?
| | RNA Precursors | 1 | 2008 | 134 | 0.070 |
Why?
| | Folic Acid | 2 | 2019 | 161 | 0.070 |
Why?
| | Gene Ontology | 2 | 2017 | 46 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 2 | 2021 | 405 | 0.070 |
Why?
| | Neoplasms | 2 | 2018 | 2082 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4384 | 0.070 |
Why?
| | Phosphorylation | 2 | 2021 | 1537 | 0.070 |
Why?
| | Uganda | 2 | 2016 | 69 | 0.060 |
Why?
| | Glucose | 2 | 2023 | 894 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2288 | 0.060 |
Why?
| | Sputum | 2 | 2016 | 284 | 0.060 |
Why?
| | Alkanesulfonates | 1 | 2023 | 6 | 0.050 |
Why?
| | Analgesics, Opioid | 1 | 2010 | 770 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2015 | 2164 | 0.050 |
Why?
| | Carboxylic Acids | 1 | 2023 | 26 | 0.050 |
Why?
| | Privacy | 1 | 2023 | 28 | 0.050 |
Why?
| | Hypertrophy | 1 | 2023 | 106 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 42 | 0.050 |
Why?
| | Pneumonia | 2 | 2020 | 561 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2023 | 1682 | 0.050 |
Why?
| | Schistosoma | 1 | 2022 | 18 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 161 | 0.050 |
Why?
| | Snails | 1 | 2022 | 32 | 0.050 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2021 | 15 | 0.050 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2021 | 14 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 185 | 0.050 |
Why?
| | Furin | 1 | 2021 | 12 | 0.050 |
Why?
| | Pregnant Women | 1 | 2023 | 126 | 0.050 |
Why?
| | Asia | 1 | 2021 | 53 | 0.050 |
Why?
| | Genetic Variation | 2 | 2021 | 854 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 41 | 0.050 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 49 | 0.050 |
Why?
| | Africa | 1 | 2021 | 92 | 0.050 |
Why?
| | Water Resources | 1 | 2021 | 7 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 112 | 0.050 |
Why?
| | Epidemiological Monitoring | 1 | 2021 | 46 | 0.050 |
Why?
| | Alanine | 1 | 2021 | 104 | 0.050 |
Why?
| | Sex Factors | 2 | 2019 | 1705 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 101 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 365 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2021 | 37 | 0.050 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 57 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2021 | 110 | 0.050 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 129 | 0.050 |
Why?
| | Europe | 1 | 2021 | 331 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 260 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 69 | 0.040 |
Why?
| | Particulate Matter | 1 | 2022 | 178 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 54 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 159 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 412 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 49 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 98 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 132 | 0.040 |
Why?
| | Colon | 1 | 2022 | 228 | 0.040 |
Why?
| | Swine | 1 | 2022 | 687 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4400 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 91 | 0.040 |
Why?
| | Cattle | 1 | 2022 | 913 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 463 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 193 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 69 | 0.040 |
Why?
| | Finland | 1 | 2019 | 69 | 0.040 |
Why?
| | Water | 1 | 2022 | 394 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 73 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 996 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 444 | 0.040 |
Why?
| | United States | 3 | 2021 | 12139 | 0.040 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 139 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 471 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2019 | 218 | 0.040 |
Why?
| | Computer Graphics | 1 | 2018 | 40 | 0.040 |
Why?
| | Leptin | 1 | 2019 | 207 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 366 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 234 | 0.040 |
Why?
| | Environmental Pollution | 1 | 2018 | 17 | 0.040 |
Why?
| | Pedigree | 1 | 2019 | 460 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2021 | 424 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 44 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 411 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.040 |
Why?
| | Maternal Health | 1 | 2018 | 42 | 0.040 |
Why?
| | Time Factors | 2 | 2021 | 6032 | 0.040 |
Why?
| | Cell Transformation, Viral | 1 | 2017 | 24 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 357 | 0.040 |
Why?
| | Caprylates | 1 | 2017 | 19 | 0.040 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 64 | 0.040 |
Why?
| | Umbilical Cord | 1 | 2017 | 80 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 381 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 716 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 93 | 0.030 |
Why?
| | Gambia | 1 | 2016 | 12 | 0.030 |
Why?
| | THP-1 Cells | 1 | 2016 | 19 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2016 | 41 | 0.030 |
Why?
| | Lod Score | 1 | 2016 | 64 | 0.030 |
Why?
| | Actins | 1 | 2018 | 373 | 0.030 |
Why?
| | ABO Blood-Group System | 1 | 2016 | 29 | 0.030 |
Why?
| | Regulon | 1 | 2016 | 32 | 0.030 |
Why?
| | Fetal Development | 1 | 2019 | 248 | 0.030 |
Why?
| | Child Health | 1 | 2018 | 127 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 1832 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 47 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2017 | 186 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2245 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 82 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2022 | 961 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 239 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 716 | 0.030 |
Why?
| | Follicular Phase | 1 | 2015 | 35 | 0.030 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2017 | 180 | 0.030 |
Why?
| | Ovulation | 1 | 2015 | 39 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 282 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 11 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 81 | 0.030 |
Why?
| | Mice, Congenic | 1 | 2015 | 21 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 36 | 0.030 |
Why?
| | Immune System | 1 | 2016 | 167 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 56 | 0.030 |
Why?
| | Hair Follicle | 1 | 2015 | 44 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 697 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 63 | 0.030 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 64 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 499 | 0.030 |
Why?
| | Heart | 1 | 2018 | 609 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 268 | 0.030 |
Why?
| | Breeding | 1 | 2014 | 54 | 0.030 |
Why?
| | Protein Kinases | 1 | 2016 | 300 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2017 | 228 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 912 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 147 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1356 | 0.030 |
Why?
| | Blood Glucose | 1 | 2023 | 1823 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 224 | 0.030 |
Why?
| | Monophenol Monooxygenase | 1 | 2013 | 6 | 0.030 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2013 | 16 | 0.030 |
Why?
| | Annexin A5 | 1 | 2013 | 21 | 0.030 |
Why?
| | Spectrophotometry | 1 | 2013 | 47 | 0.030 |
Why?
| | Melanins | 1 | 2013 | 16 | 0.030 |
Why?
| | Education | 1 | 2013 | 91 | 0.030 |
Why?
| | Catalase | 1 | 2013 | 118 | 0.030 |
Why?
| | Administration, Topical | 1 | 2013 | 137 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1110 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 349 | 0.030 |
Why?
| | Neutrophils | 1 | 2017 | 1072 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 384 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 310 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 497 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 519 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 196 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1008 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 302 | 0.020 |
Why?
| | Receptors, GABA | 1 | 2010 | 8 | 0.020 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 11 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 10 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2016 | 733 | 0.020 |
Why?
| | Cell Movement | 1 | 2015 | 852 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 24 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 40 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 135 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4061 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 919 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1589 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 829 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1004 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 159 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 262 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 141 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1234 | 0.020 |
Why?
| | Antioxidants | 1 | 2013 | 527 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2009 | 355 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2009 | 112 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2088 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4594 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1359 | 0.020 |
Why?
| | Histones | 1 | 2013 | 528 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 803 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 2690 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 521 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 3802 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1872 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 12504 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 3473 | 0.010 |
Why?
|
|
Kechris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|